Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS

International Journal of Molecular Sciences
Savina ApolloniCinzia Volonté

Abstract

(1) Background: Amyotrophic lateral sclerosis (ALS) is a multifactorial non-cell autonomous disease where activation of microglia and astrocytes largely contributes to motor neurons death. Heat shock proteins have been demonstrated to promote neuronal survival and exert a strong anti-inflammatory action in glia. Having previously shown that the pharmacological increase of the histamine content in the central nervous system (CNS) of SOD1-G93A mice decreases neuroinflammation, reduces motor neuron death, and increases mice life span, here we examined whether this effect could be mediated by an enhancement of the heat shock response. (2) Methods: Heat shock protein expression was analyzed in vitro and in vivo. Histamine was provided to primary microglia and NSC-34 motor neurons expressing the SOD1-G93A mutation. The brain permeable histamine precursor histidine was chronically administered to symptomatic SOD1-G93A mice. Spine density was measured by Golgi-staining in motor cortex of histidine-treated SOD1-G93A mice. (3) Results: We demonstrate that histamine activates the heat shock response in cultured SOD1-G93A microglia and motor neurons. In SOD1-G93A mice, histidine augments the protein content of GRP78 and Hsp70 in spinal cor...Continue Reading

References

Jul 1, 1992·Developmental Dynamics : an Official Publication of the American Association of Anatomists·N R CashmanJ P Antel
Apr 8, 1998·Journal of Neuroscience Methods·R Gibb, B Kolb
Dec 3, 1999·Journal of Neurochemistry·S VukosavicS Przedborski
Sep 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Alberto FerriMaria Teresa Carrì
Feb 14, 2007·The Journal of Biological Chemistry·Jozsef GalHaining Zhu
May 3, 2007·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Zhen ZhengMidori A Yenari
Feb 13, 2008·Journal of Cellular and Molecular Medicine·D LanneauC Garrido
Apr 17, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Savina ApolloniNadia D'Ambrosi
Aug 28, 2013·Pharmacology & Therapeutics·Bernadett KalmarLinda Greensmith
Jan 13, 2015·Trends in Neurosciences·Ling ShanDick F Swaab
May 31, 2015·Neuropharmacology·Armin ZlomuzicaEkrem Dere
Dec 10, 2015·Current Pharmaceutical Design·Ramón CacabelosGjumrakch Aliev
Apr 27, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Daigo MiyazakiShu-Ichi Ikeda
Aug 24, 2016·Journal of Neuroinflammation·Savina ApolloniCinzia Volonté
Nov 11, 2016·Nature·J Paul TaylorDon W Cleveland
Feb 23, 2017·Pharmacology & Therapeutics·Weiwei Hu, Zhong Chen
Apr 21, 2017·Frontiers in Neuroscience·Caty Casas
May 10, 2017·Frontiers in Neuroscience·Stuart K Calderwood, Ayesha Murshid
Jun 10, 2017·The EMBO Journal·Lorenzo GalluzziGuido Kroemer
Sep 6, 2017·Frontiers in Cellular Neuroscience·Paola FabbrizioCinzia Volonté
Sep 20, 2017·Molecular Neurodegeneration·Rebecca San GilHeath Ecroyd
Sep 26, 2017·Frontiers in Molecular Neuroscience·Bernadett Kalmar, Linda Greensmith
Jan 18, 2018·EMBO Molecular Medicine·Amit U JoshiDaria Mochly-Rosen
Mar 9, 2018·Frontiers in Neuroscience·Emily R SeminaryAllison D Ebert
Nov 8, 2018·Mayo Clinic Proceedings·Björn OskarssonNathan P Staff
Jan 22, 2019·Lancet Neurology·David R Beers, Stanley H Appel
Apr 26, 2019·Journal of Cachexia, Sarcopenia and Muscle·Savina ApolloniCinzia Volonté
Jun 7, 2019·Cell Stress & Chaperones·Benjamin E ClarkeLinda Greensmith

❮ Previous
Next ❯

Citations

May 1, 2021·International Journal of Molecular Sciences·Francesco LiguoriCinzia Volonté

❮ Previous
Next ❯

Software Mentioned

Kodak Image Station
Zen
Neurolucida
MedCalc

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.